Cataract surgery rates in Ontario, Canada, from 1992 to 2004: more surgeries with fewer ophthalmologists.

BACKGROUND: To evaluate trends in cataract surgeries in Ontario between 1992 and 2004. METHODS: A retrospective analysis of the number of cataract surgeries performed in Ontario from April 1992 to March 2005. The estimated prevalence of cataract and cataract surgeries per 1000 persons at risk was calculated. RESULTS: The number of cataract surgeries in Ontario increased from 44,943 in 1992 to 109,506 in 2004 (143.6%, 12.08% annual increase). The number of cataract surgeries per 1000 patients at risk of cataract increased from 64.6 in 1992 to 115.65 in 2004 (79%, 4.97% increase per year). This rate was strongly positively correlated with time and with the increase in the Ontario population (r = 0.920 and r = 0.922, respectively; p < 0.001). The number of ophthalmologists increased by 5.3% from 1992 to 1997 and then decreased by 2.9% by 2004. This change was not correlated with the cataract surgery rates (r = 0.475; p = 0.10). However, the number of ophthalmologists per million population decreased by 13.4% between 1992 and 2004. This number had a statistically negative correlation with cataract surgery rates (r = -0.757; p < 0.01). INTERPRETATION: There has been a significant increase in the number of cataract surgeries in Ontario despite a decrease in the number of ophthalmologists per million population.

Optic nerve head blood flow measurements in non-arteritic anterior ischaemic optic neuropathy.

PURPOSE: To determine whether a decrease in blood flow, measured by the Heidelberg retiinal flowmeter, can characterise a disc at risk and predict the occurrence of non-arteritic anterior ischaemic optic neuropathy (NAION). METHODS: Blood flow, volume and velocity were measured in the optic nerve heads of 14 unaffected fellow eyes of patients with unilateral NAION, and compared with those of the affected eyes and of the eyes of 7 age-matched healthy controls. RESULTS: The affected eyes were found to differ from the unaffected eyes in all three haemodynamic parameters. Flow (measured in arbitrary units) is the most important parameter to be taken into consideration. Blood flow was significantly lower in affected than in unaffected eyes (upper rim, p < 0.05; lower rim, p < 0.025). It was also significantly lower in the unaffected eyes than in the healthy control eyes (p < 0.005, upper and lower rims), and in the affected eyes than in the control eyes (p < 0.00005, upper and lower rims). CONCLUSION: Decreased blood flow in the optic nerve head may indicate a risk for NAION and be considered a characteristic of the disc at risk.

Recurrent choroidal detachment following combined trabeculectomy and cataract extraction.

Two patients with glaucoma who underwent uneventful trabeculectomy and extracapsular cataract extraction with posterior chamber intraocular lens implantation, experienced late and recurrent choroidal detachment. Both patients received aqueous suppressant therapy before and after surgery. Hypotony and choroidal detachment occurred 7 months and 15 months after the combined surgery. There was no shallowing of the anterior chamber or leakage from the filtering blebs, and there were no signs of inflammation. The choroidal detachment completely resolved in the two patients 4 days and 4 weeks following discontinuation of the aqueous suppressant therapy.

Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.

AIMS: The effectiveness of instillation of mitomycin C eyedrops on the recurrence rate of pterygium was assessed in patients undergoing primary pterygium surgery. Any side effects were also noted. METHODS: Primary pterygia in 38 consecutive patients were surgically excised during July to December 1992. After surgery, mitomycin C 0.02% eyedrops twice daily for 5 days as well as dexamethasone 0.1% four times tapered for the next 6 weeks were instilled. Postoperative follow up ranged from 6 to 11 months. RESULTS: In one patient the pterygium recurred after 3 months (recurrence rate 2.6%). The side effects encountered were: avascularised sclera in 13 cases between 1-10 months postoperatively; ocular discomfort and lacrimation in five cases; superficial punctate keratitis during the first month in three cases; pyogenic granuloma in two cases. In one patient steroid induced increased intraocular pressure was found 4 weeks after surgery. The adverse side effects were all mild, self limiting, and easily treated. CONCLUSION: This study suggests that postoperative instillation of mitomycin C 0.02% eyedrops twice daily for 5 days following excision of primary pterygium is an effective and safe treatment to obviate pterygium recurrence.